BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22078291)

  • 21. Differential expression of alpha-methylacyl coenzyme A racemase in adenocarcinomas of the small and large intestines.
    Chen ZM; Ritter JH; Wang HL
    Am J Surg Pathol; 2005 Jul; 29(7):890-6. PubMed ID: 15958853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach.
    Hayakawa M; Nishikura K; Ajioka Y; Aoyagi Y; Terai S
    Pathol Int; 2017 Mar; 67(3):131-140. PubMed ID: 28088838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
    Lee OJ; Kim HJ; Kim JR; Watanabe H
    Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
    Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
    Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase.
    Scarpelli M; Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2012; 25(1):67-74. PubMed ID: 22507319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
    Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Achievements in morphological diagnosis of prostatic cancer: alpha-methylacyl-coenzyme-A-racemase--a new marker of malignant cell transformation].
    Pozharisskiĭ KM; Leenman EE; Arzumanov AA
    Arkh Patol; 2005; 67(5):15-9. PubMed ID: 16323473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
    Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
    J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
    Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alpha-methylacyl-CoA racemase: a useful marker for diagnosis of prostatic carcinoma].
    Jiang Z; Ma K; Wu CL; Yang XJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):401-3. PubMed ID: 15498205
    [No Abstract]   [Full Text] [Related]  

  • 34. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
    Domori K; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
    Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
    Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of alpha-methylacyl-CoA racemase in vaginal gastric-type adenocarcinoma and uterine clear cell carcinoma.
    Hu J; Lu Y; Tang N; Li L; Guo P; Zhang Y
    Indian J Pathol Microbiol; 2020; 63(1):49-52. PubMed ID: 32031122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival.
    Mroz A; Kiedrowski M; Lewandowski Z
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):313-7. PubMed ID: 23235347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
    Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
    Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.